Harmony Biosciences Holdings
Save
1.67B
Market cap
13.78x
Current P/E
10.98x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020.
Similar securities
Based on sector and market capitalization
Report issue